Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / SHS USD
-
Total 13F shares
-
31,247,857
-
Share change
-
+420,268
-
Total reported value
-
$187,481,000
-
Price per share
-
$6.00
-
Number of holders
-
64
-
Value change
-
-$625,383
-
Number of buys
-
43
-
Number of sells
-
35
Institutional Holders of STRONGBRIDGE BIOPHARMA PLC - SHS USD (SBBP) as of Q2 2018
As of 30 Jun 2018,
STRONGBRIDGE BIOPHARMA PLC - SHS USD (SBBP) was held by
64 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
31,247,857 shares.
The largest 10 holders included
CAXTON CORP, Lyon Street Capital, LLC, NEA Management Company, LLC, Broadfin Capital, LLC, ARMISTICE CAPITAL, LLC, Vivo Capital, LLC, Opaleye Management Inc., Park West Asset Management LLC, Harvest Capital Strategies LLC, and SPHERA FUNDS MANAGEMENT LTD..
This page lists
64
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.